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Abstract
Plasmablastic lymphoma (PBL) is a rare form of non-
Hodgkin’s lymphoma that is associated with human 
immunodeficiency virus (HIV) infection. Although 
PBL is most commonly observed in the oral cavity 
of HIV-positive patients, it can also be observed at 
extra-oral sites in HIV-negative patients. This report 
represents an unusual case of HIV-negative PBL 
that occurred in the sigmoid colon. This patient had 
a history of systemic lupus  erythematosus and an 
underlying immunosuppressive state from long term 
steroid therapy. The lymphoma cells were positive for 
CD138, kappa light chain restriction and Epstein-Barr 
virus and negative for CD20/L26, CD3, CD79a, UCHL1 
(CD45RO) and cytokeratin (AE1/AE3). The patient died 
approximately 2 mo after the operation. In the present 
paper, we review cases of PBL of the colon in HIV-
negative patients.
Key words: Plasmablastic lymphoma; Sigmoid colon; Human 
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Core tip: Plasmablastic lymphoma (PBL) is a rare form of 
non-Hodgkin’s lymphoma that is associated with human 
immunodeficiency virus (HIV) infection. Although PBL is 
most commonly observed in the oral cavity of HIV-positive 
patients, it can also be observed at extra-oral sites in HIV-
negative patients with an underlying immunosuppressive 
state. The gastrointestinal tract and skin are the most 
commonly involved extra-oral organ systems and cases 
Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.3748/wjg.v21.i24.7598
World J Gastroenterol  2015 June 28; 21(24): 7598-7603
 ISSN 1007-9327 (print)  ISSN 2219-2840 (online)
© 2015 Baishideng Publishing Group Inc. All rights reserved.
of PBL in the colon are unusual. We report a case of HIV-
negative PBL that occurred in the sigmoid colon.
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INTRODUCTION
Considered as a diffuse large B-cell non-Hodgkin’s 
lymphoma variant, plasmablastic lymphoma (PBL) is 
an aggressive and rapidly growing lymphoma charac-
terized by weak/absent expression of conventional 
B-cell markers and by strong expression of plasma cell 
markers. PBL was described as a new disease entity in 
the 4th WHO classification[1]. PBL was first reported in the 
oral cavity in the setting of human immunodeficiency 
virus (HIV) in 1997 by Delecluse et al[2], originally 
described in 16 cases of a variant of diffuse large B-cell 
lymphoma (DLBCL). Although PBL is strongly associated 
with HIV infection, an increasing number of cases have 
recently been recognized in a non-HIV population, as 
in our case[3]. These cases often occur in patients with 
an underlying immunosuppressive state, such as from 
solid organ and bone marrow transplantation, and 
from lymphoproliferative or autoimmune disorders. A 
characteristic feature of PBL is its rapidly progressive 
clinical course. However, the overall survival is better 
in HIV-positive patients treated with highly active 
antiretroviral therapy (HAART) and appropriate chemo-
therapy than in HIV-negative patients[4]. 
Several reports have described the occurrence of 
PBL in extra-oral sites, including the skin, stomach, 
small intestine, anal mucosa or perianal area, lung, 
liver, retroperitoneum and other regions[5-10].
We describe a case of PBL of the sigmoid colon in 
a HIV-negative but Epstein-Barr virus (EBV)-positive 
patient who presented with gastrointestinal bleeding. 
According to our research, before our case, there 
have only been four cases of PBL of the colon in an 
HIV-negative patient. Herein, we review the literature 
of rare cases of PBL of the colon.
CASE REPORT
An 86-year-old female was admitted to our hospital’s 
emergency department because of bloody stool. On 
physical examination, she had no abdominal pain 
and no tenderness with guarding or rebound. At 
presentation, laboratory data revealed the following 
results: white blood count at 13100 cells/mm2, 
hemoglobin at 13.2 mg/dL, C-reactive protein at 2.1 
mg/dL, and negative status for hepatitis B and C and 
for human T-cell lymphotropic virus 1. The patient 
was known to have systemic lupus erythematosus 
(SLE) and type 2 diabetes mellitus. The patient was 
receiving steroidal treatment for SLE. A computed 
tomography scan of her abdomen revealed a mass 
measuring 5 cm, multiple diverticula in the sigmoid 
colon and enlarged lymph nodes in the sigmoid 
mesentery (Figure 1). Free air was not detected in 
the abdominal cavity. Colonoscopy was performed 
and a tumor with bleeding in the sigmoid colon was 
revealed. Because bleeding due to sigmoid colon 
cancer was suspected, sigmoidectomy with Hartmann’s 
procedure was urgently performed. The excised 
material revealed the tumor to be tender, 5 cm × 4.5 
cm in size, and displaying the diverticulosis (Figure 2A). 
On the cut surface, the tumor was soft, consistent with 
hemorrhage (Figure 2B). Microscopically, the tumor 
cells had large hyperchromatic nuclei with prominent 
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Figure 1  Computed tomography of abdomen. Computed tomography scan 
showed a mass measuring 5 cm in diameter, multiple diverticula in the sigmoid 
colon and enlarged lymph nodes in the sigmoid mesentery.
B
A
Figure 2  Gross appearance of the primary tumor lesion. A: A tumor (5 cm 
in diameter) is present in the sigmoid colon. Coagulation is on the surface; B: 
The tumor showed hemorrhage on the surface and a white mass within and 
was soft in consistency.
nucleoli. Some tumor cells showed plasmacytic 
differentiation (Figure 3A). There was no epithelial 
component. Therefore, malignant lymphoma or diffuse 
lymphoma was suspected.
Immunohistochemical examination revealed that 
the tumor cells were negative for CD20/L26 (Figure 





Figure 3  Plasmablastic lymphoma of the sigmoid colon. A: Tumor cells have large hyperchromatic nuclei with prominent nucleoli. Some tumor cells showed 
plasmacytic differentiation [hematoxylin and eosin (HE) staining, original magnification × 400]; B: The atypical cells are negative for the B-cell marker CD20 (original 
magnification × 400); C: The atypical cells are diffusely positive for the plasma cell marker CD138 (original magnification × 400); D: The nuclei of the atypical cells are 
positive for EBER, which is Epstein-Barr encoded RNA (original magnification × 400); E: The atypical cells are negative for the leukocyte common antigen CD45RO 
(UCHL1) (original magnification × 400); F: The atypical cells are negative for the T-cell marker CD3 (original magnification × 400); G: The atypical cells are negative 
for the pan-B-cell marker CD79a (original magnification × 400).
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EBV infection was detected in 72% of PBL cases[17]. 
However, EBV infection has been detected in only 17% 
of HIV-negative PBL cases, which suggests that PBL 
pathogenesis is not specific to EBV infection[5].
The histological appearance of PBL is usually 
monomorphic with a diffuse lymphoid infiltrate and 
cohesive growth pattern[18]. The main differential 
diagnosis of PBL includes other forms of DLBCL, 
plasmacytoma/myeloma, Burkitt’s lymphomas, poorly 
differentiated carcinoma and malignant melanoma; for 
such a differential diagnosis, the help of morphological 
characteristics and behavior are often effective[16]. 
Unlike PBL, DLBCL always expresses CD20, CD45-RA 
and CD79a. Plasmacytoma typically consists of mature 
plasma cells without a high rate of mitotic activity. 
Burkitt’s lymphomas express a membrane-bound IgM 
heavy chain isotype. PBL expresses immunoreactivity 
for plasma cell markers (CD38, CD138) and is weakly 
positive or negative for CD45 and CD20. CD79a is 
positive in approximately 50%-85% of all PBL cases[16]. 
CD138 is a highly specific and sensitive marker of 
plasmacytic differentiation within the spectrum of 
hematological malignancy. CD138 reactivity has been 
reported with variable frequency in immunoblastic 
diffuse large B-cell lymphoma. CD56 and cyclin D1 
are usually negative. However, a differential diagnosis 
between PBL and plasmacytoma is difficult without 
histological examination. 
The most notable feature of PBL is its predilection 
for the oral cavity. Most patients with PBL present with 
a primary oral lesion, often complaining of a toothache 
or tooth abscess[19]. PBL can be observed at extra-oral 
sites in HIV-negative patients. As for extra-oral organ 
systems, the gastrointestinal tract and skin are the 
most commonly involved[19] but only four PBL cases of 
the colon in HIV-negative patients have been reported 
before our case[4,20,21] (Table 1). 
The general prognosis of PBL is very poor, with 
a rapidly progressive clinical course[19]. However, 
clinicopathological characteristics of PBL patients 
differ between HIV-positive and HIV-negative status, 
where HIV-positive patients have better response 
to chemotherapy and longer survival[5]. For HIV-
positive PBL patients, recent reports have noted 
improved survival when treating with both HAART and 
appropriate chemotherapy, such as cyclophosphamide, 
3B), CD3, CD79a, UCHL1 (CD45RO) and cytokeratin 
(AE1/AE3), but positive for CD138 (Figure 3C), kappa 
light chain restriction and EBV (Figure 3D). The patient’s 
HIV negative status was proven after the surgery. 
Based on these results, our final diagnosis was PBL. The 
patient continued to deteriorate clinically and developed 
multiorgan failure. The patient died approximately 2 
mo after surgery after refusing chemotherapy and 
radiotherapy. Autopsy was not performed. 
DISCUSSION
PBL has been recognized as a distinct entity, a 
subtype of diffuse large B-cell lymphoma, by the 
WHO classification of lymphoproliferative disorders[11]. 
PBL accounts for 1.5% of all nodal non-Hodgkin’
s lymphomas and has a strong predilection for 
immunodeficiency, particularly HIV. In patients with 
PBL in HIV infection, the median age was 38 years 
with a male predominance of 7:1. The prognosis 
remains poorer than that of other DLBCL[12]. The risk 
of developing non-Hodgkin’s lymphoma is 200 times 
higher in HIV-positive patients than in otherwise 
healthy persons. However, an increasing number of 
PBL cases have recently been recognized in patients 
without HIV infection. In HIV-negative individuals, 
PBL cases have been reported after solid organ 
transplantation, in association with steroid therapy 
for autoimmune disease, and some other types of 
immunosuppression[13,14]. About one-third of PBL-
diagnosed HIV negative patients have presented 
with an underlying immunosuppressive state[15]. The 
present patient had a diagnosis of SLE and a history 
of steroidal treatment for 35 years before developing 
lymphoma. This steroidal therapy probably led to the 
iatrogenic immunocompromised state. There was 
no family history of any hematological malignancies. 
Except for the steroidal therapy, our patient had never 
received any other treatment which could lead to an 
iatrogenic immunocompromised state.
The present case is HIV-negative but EBV-positive. 
EBV plays an important role in the tumorigenesis 
of HIV-associated PBL[16]. HIV infection creates a 
favorable environment for chronic EBV infection, with a 
subsequent latency that predisposes EBV-transformed 
B-cells to become malignant. It has been reported that 
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Table 1  Patient clinical, tumor, immunohistochemical and Epstein-Barr virus status characteristics
Patient Age Gender Primary site CD3 CD20 CD45 CD79a CD138 EBV Cyclin D1 CD56
1 56 M Sigmoid - - - - + - ND ND
21 29 M Colon - - +/- - + + ND ND
3 75 M Cecum - - - - + - - -
4 77 F Cecum - - ND +/- + ND - ND
52 86 F Sigmoid - - - - + + ND ND
1Patient with history of ulcerative colitis; 2Present patient. M: Male; F: Female; ND: Not determined; CD3: T-cell marker; CD20: B-cell marker; CD45: 
Leukocyte common antigen; CD79a: Pan-B-cell marker; CD138: Plasma cell marker; EBV: Epstein-Barr virus; Cyclin D1: Mantle cell lymphoma marker; 
CD56: NK-cell marker.
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doxorubicin, vincristine and prednisone, with similar 
outcomes for HIV-infected patients to other non-
Hodgkin’s lymphomas[19]. Several patients have been 
documented to have survived for more than 3 years 
from the time of initial diagnosis of PBL, usually with a 
combination of HAART plus chemotherapy[19]. 
Extra-oral PBL can often occur in HIV-negative 
patients and is highly aggressive, with a poor prognosis. 
Although identifying extra-oral PBL requires familiarity 
with lymphoma variants and related differential 
diagnosis procedures, PBL should be suspected if 
the patient is immunosuppressed. A high index of 
suspicion by the clinician and pathologist might lead to 




An 86-year-old female was admitted to our hospital’s emergency department 
because of bloody stool. 
Clinical diagnosis
The physical sign of our case was bloody stool; on physical examination, she 
had no abdominal pain and no tenderness with guarding or rebound.
Differential diagnosis
Diffuse large B-cell lymphoma, plasmacytoma/myeloma, Burkitt’s lymphomas, 
poorly differentiated carcinoma and malignant melanoma. 
Laboratory diagnosis
Laboratory data revealed the following results: white blood count at 13,100 
cells/mm2, hemoglobin at 13.2 mg/dl, C-reactive protein at 2.1 mg/dl, and 
negative status for hepatitis B and C and for human T-cell lymphotropic virus 1. 
Imaging diagnosis
A computed tomography scan of our patient’s abdomen revealed a mass 
measuring 5 cm, multiple diverticula in the sigmoid colon and enlarged lymph 
nodes in the sigmoid mesentery.
Pathological diagnosis
Microscopically, the tumor cells had large hyperchromatic nuclei with prominent 
nucleoli and some tumor cells showed plasmacytic differentiation, while 
immunohistochemical examination revealed that the tumor cells were negative 
for CD20/L26, CD3, CD79a, UCHL1 (CD45RO) and cytokeratin (AE1/AE3), but 
positive for CD138, kappa light chain restriction and Epstein-Barr virus (EBV). 
Treatment
Sigmoidectomy with Hartmann’s procedure was performed. 
Term explanation 
Considered as a diffuse large B-cell non-Hodgkin’s lymphoma variant, 
plasmablastic lymphoma (PBL) was described as a new disease entity in the 4th 
WHO classification.
Experiences and lessons
Extra-oral PBL can often occur in human immunodeficiency virus (HIV)-negative 
patients and is highly aggressive with a poor prognosis. However, a high index 
of suspicion by the clinician and pathologist might lead to initiating appropriate 
treatments and account for better outcomes.
Peer-review
This is a case report of PBL which is a rare form of non-Hodgkin’s lymphoma 
that is associated with HIV infection. The author of this manuscript should give 
more information about this kind of lymphoma, including the epidemiology and 
distribution of the disease.
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